SeekingAlpha · Aug 10, 2026
Nihon Kohden Corporation 2027 Q1 - Results - Earnings Call Presentation
2026-08-10. The following slide deck was published by Nihon Kohden Corporation in conjunction with their 2027 Q1 earnings call.
NH
OTC · NHNKY
Nihon Kohden Corporation
Healthcare · Medical - Devices
$9.65
Down-$0.11 (-1.13%)
Updated Sep 7, 2026, 6:55 AM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 3.46B
- P/E ratio
- 14.53
- Dividend yield
- 2.04%
- 52-week range
- — – —
- Volume
- 500
- Avg. volume
- 13.47K
Price performance
NHNKY price history
1M range · 0 trading sessions · Daily adjusted prices
NHNKY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest NHNKY news
The latest Smart Investors Daily articles mentioning NHNKY.
Stock researchCompany · Overview
NHNKY research
Overview
Company profile and research snapshot.
Company profile
NIHON KOHDEN UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
businesswire.com · Dec 4, 2025
Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, held December 5–9 in Atlanta. Attendees are invited to Booth #725 to explore solutions shaped through extensive collaboration with the clinicians who use them—bringing together mobility, connectivity and performance to advance neurological care. With a history of advancing EEG technology that predates.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
